SLN - Silence reveals promising phase 1 results from rare blood disorder asset divesiran
2024-06-27 14:33:58 ET
More on Silence Therapeutics
- Silence Therapeutics: PV Data For Consideration After ASCVD Treatment Results
- Silence Therapeutics achieves $2M research milestone payment from Hansoh Pharma
- Silence Therapeutics achieves $2M research milestone payment from Hansoh collaboration
- Seeking Alpha’s Quant Rating on Silence Therapeutics
- Historical earnings data for Silence Therapeutics